Seeing Is Believing
Currently out of the existing stock ratings of Madhu Kumar, 176 are a BUY (67.43%), 62 are a HOLD (23.75%), 23 are a SELL (8.81%).
Analyst Madhu Kumar, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 59.44% that have a potential upside of 41.03% achieved within 183 days.
Madhu Kumar’s has documented 484 price targets and ratings displayed on 52 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on DVAX, Dynavax Technologies at 11-Feb-2025.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 12/29/2020. The price target of $69 was fulfilled within 10 days with a profit of $26.64 (62.89%) receiving and performance score of 62.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
$0.62 (14.16%)
$5
1 months 28 days ago
(10-Aug-2025)
4/13 (30.77%)
$1.65 (49.25%)
136
Buy
$5
$0.62 (14.16%)
$5
8 months 18 days ago
(20-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
$5
$0.62 (14.16%)
$4
1 years 2 months 7 days ago
(01-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$5
$0.62 (14.16%)
3 years 8 months 7 days ago
(01-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
4 years 3 months 11 days ago
(27-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
What Year was the first public recommendation made by Madhu Kumar?